Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV001652631 | SCV001865781 | benign | not provided | 2019-08-20 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002440829 | SCV002745312 | likely benign | Inborn genetic diseases | 2020-01-23 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Breakthrough Genomics, |
RCV001652631 | SCV005277030 | benign | not provided | criteria provided, single submitter | not provided | ||
Labcorp Genetics |
RCV005225447 | SCV005868710 | benign | Lower motor neuron syndrome with late-adult onset; Frontotemporal dementia and/or amyotrophic lateral sclerosis 2; Autosomal dominant mitochondrial myopathy with exercise intolerance | 2024-03-22 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV003975806 | SCV004794770 | benign | CHCHD10-related disorder | 2019-09-10 | no assertion criteria provided | clinical testing | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |